cas 155206-00-1, Bimatoprost | Articles data

Articles about 155206-00-1Total 34 be found

Article title
Article abstract
Author
Journal number and time
Download

A new synthetic approach to prostaglandin analogues: Synthesis of bimatoprost via lipase enzymatic catalysis
A simple, convenient and efficient synthetic approach for the synthesis of (15S) bimatoprost (4) via lipase enzyme mediated stereo selective reduction from chiral precursor Corey lactone diol as substrate was described. Swern oxidation, lipase enzymatic reduction and Wittig reaction conditions are used as key steps for the synthesis of bimatoprost. This method was found to be an efficient with considerable yield, cost effective and minimized the synthetic steps compared to reported procedures.
Kamidi, Vijendhar,Kale, Pooja,Boodida, Sathyanarayana
p. 2767 - 2770
(2017)
Read Online

Preparation method of bemeprost
The invention discloses a preparation method of bemeprost, which comprises the following steps: (1) in a first solvent, carrying out oxidation reaction on a compound 1 in an oxidation system to generate a compound 2; (2) in a second solvent, under the action of alkali, mixing the compound 2 with a compound 7 for reaction to generate a compound 3; (3) carrying out reduction reaction on the compound3 in a third solvent under the action of a first reducing agent to generate a compound 4; (4) in a fourth solvent, carrying out reduction reaction on the compound 4 under the action of a second reducing agent to generate a compound 5; and (5) in a fifth solvent, under the action of alkali, carrying out the following reaction on the compound 5 and the compound 8 to generate bemeprost of a compound6. According to the preparation method disclosed by the invention, the operation steps are remarkably simplified, the reaction conditions are mild, and the operation is simple and convenient; raw materials are cheap and easy to obtain, and cost is reduced; the product yield is high, and the method is suitable for industrial production.
-
Paragraph 0044; 0057-0059; 0060; 0073-0075; 0076; 0089-0091

(2021/03/06)

Access to a Key Building Block for the Prostaglandin Family via Stereocontrolled Organocatalytic Baeyer–Villiger Oxidation
A new protocol for the construction of a crucial bicyclic lactone of prostaglandins using a stereocontrolled organocatalytic Baeyer–Villiger (B-V) oxidation was developed. The key B-V oxidation of a racemic cyclobutanone derivative with aqueous hydrogen peroxide has enabled an early-stage construction of a bicyclic lactone skeleton in high enantiomeric excess (up to 95 %). The generated bicyclic lactone is fully primed with two desired stereocenters and enabled the synthesis of the entire family of prostaglandins according to Corey′s route. Furthermore, the reactivity and enantioselectivity of B-V oxidation of racemic bicyclic cyclobutanones were evaluated and 90–99 % ee was obtained, representing one of the most efficient routes to chiral lactones. This study further facilitates the synthesis of prostaglandins and chiral lactone-containing natural products to promote drug discovery.
Zhu, Kejie,Hu, Sha,Liu, Minjie,Peng, Haihui,Chen, Fen-Er
p. 9923 - 9927
(2019/05/16)

PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE
The present invention relates to a process for preparing the hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]- 3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester of formula (I). In accordance with the present invention, the compound (I) can be efficiently prepared with high purity by coupling bimatoprost in a boronate protected form with 6-(nitrooxy)hexanoyl chloride and removing the boronate protecting group. The 6-(nitrooxy)hexanoyl chloride intermediate is prepared by ring-opening reaction of 2-caprolactone and subsequent nitration of the 6-hydroxyhexanoic acid potassium salt with a mixture of HNO3 and H2SO4 in dichloromethane.
-
(2019/09/12)

PROCESS FOR THE PREPARATION OF BIMATOPROST
It is provided a process for the preparation of bimatoprost, which comprises: a) reacting a compound of formula (III) with ethylamine in the presence of a suitable solvent; and b) deprotecting compound obtained in step a) to obtain bimatoprost, wherein R1 is selected from (C1-C16)alkyl, (C1C16)haloalkyl, (C2-C16)alkenyl, (C2-C16)haloalkenyl, (C1-C16)alkoxy(C1-C16)alkyl, aryl, (C1-C16)alkylaryl, allyl, - (CH2-CH2-O)n-CH3 wherein n = 1, 2, 3 or 4, and -CH(O-CH2-CH2)2; R2 is selected from H, (C1-C16)alkyl, (C1-C16)haloalkyl, (C2-C16)alkenyl, (C2- C16)haloalkenyl, (C1-C16)alkoxy(CrC16)alkyl, aryl, (C1-C16)alkylaryl, allyl; or, alternatively, R1 and R2 taken together are selected from -CH2-CH2-CH2-, -CH2-CH2-, -O-CH2-CH2-, and -O-CH=CH-. There are also provided intermediates useful in such preparation process.
-
(2017/11/15)

Novel method for preparing Prostaglandin derivatives
Provided is a novel method for preparing prostaglandin derivatives. The method is suitable for mass production by effectively manufacturing prostaglandin derivatives with high yield. The method comprises the following steps: (S-1) adding a first reducing agent to a prostaglandin intermediate compound represented by chemical formula II and manufacturing a compound represented by chemical formula III; (S-2) manufacturing a compound represented by chemical formula IV from the compound represented by chemical formula III in the presence of a base; (S-3) adding a second reducing agent to the compound represented by chemical formula IV and manufacturing a compound represented by chemical formula V; and (S-4) performing Wittig reaction of the compound represented by chemical formula V and a compound represented by chemical formula VI, and manufacturing a compound represented by chemical formula I.COPYRIGHT KIPO 2017
-
Paragraph 0090; 0093; 0128-0130

(2017/10/31)

Prostanoid used for the synthesis of pharmaceutical intermediates and its preparation method
Disclosed is an intermediate (structural formula I) for synthesizing prostaglandin medicines and preparation method therefor. The intermediate is used for synthesizing prostaglandin medicines, such as bimatoprost, travoprost, latanoprost, etc. The intermediate is prepared by means of hemiacetal Wittig reactions and derivatization thereof.
-
(2016/10/07)

PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF ISOMER FREE PROSTAGLANDINS
Novel processes for the preparation of a compound of Formula I-2 substantially free of the 5,6-trans isomer: wherein R2, R3 and R4 are as defined in the specification are provided. Novel intermediates for the preparations of isomer free Prostaglandins and derivatives thereof are also provided.
-
(2015/02/25)

Compound And Method
A compound of formula (I): (I) wherein Y is, Z is OR10, NR11R11 SR11, S(0)R11 S02R11, R10 is H, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted heterocyclyl, CO—R11, or a protecting group, and R11 is optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted heterocyclyl, or alkoxyl; a process for making a compound of formula (I); and a process for making a prostaglandin or a prostaglandin analogue using a compound of formula (I). wherein Y is
-
Paragraph 0591-0598

(2015/06/17)

PROCESS FOR PREPARATION OF PROSTAGLANDIN F2 ALPHA ANALOGUES
A convergent synthesis of the prostaglandin F2α analogues, travoprost and bimatoprost, was developed employing Julia-Lythgoe olefination of the structurally advanced phenylsulfone with an enantiomerically pure aldehyde ω-chain synthon. The novel convergent strategy allows the synthesis of a whole series of prostaglandin analogues of high purity from a common and structurally advanced prostaglandin intermediate.
-
Paragraph 0288 - 0291

(2015/02/19)

Synthesis of prostaglandin analogues, latanoprost and bimatoprost, using organocatalysis via a key bicyclic enal intermediate
Two antiglaucoma drugs, bimatoprost and latanoprost, which are analogues of the prostaglandin, PGF2?±, have been synthesized in just 7 and 8 steps, respectively. The syntheses employ an organocatalytic aldol reaction that converts succinaldehyde into a key bicyclic enal intermediate, which is primed for attachment of the required lower and upper side chains. By utilizing the crystalline lactone, the drug molecules were prepared in >99% ee.
Pr??vost, S??bastien,Thai, Karen,Sch??tzenmeister, Nina,Coulthard, Graeme,Erb, William,Aggarwal, Varinder K.
supporting information
p. 504 - 507
(2015/03/05)

Processes for the preparation of isomer free prostaglandins
Novel processes for the preparation of a compound of Formula I-2 substantially free of the 5,6-trans isomer: wherein R2, R3 and R4 are as defined in the specification are provided. Novel intermediates for the preparations of isomer free Prostaglandins and derivatives thereof are also provided.
-
Paragraph 0269; 0270; 0271

(2015/03/03)

NOVEL PROCESSES FOR THE PREPARATION OF PROSTAGLANDIN AMIDES
The subject of the invention is process for the preparation of the prostaglandin amides of the general formula I, where in the formula the bonds marked with dotted lines may be single or double bonds, in the case of double bounds at positions 5,6 and 13,14 they may be in cis or in trans orientation, Q stands for a hydroxyl-group and Z stands for a hydroxyl- or oxo-group, R1 and R2 independently represent hydrogen atom or a straight or branched C1-10 alkyl- or aralkyl- group, optionally substituted with —ONO2 group, or an aralkyl- or aryl- group, which contains heteroatom, R3 represents a straight or branched, saturated or unsaturated C4-6 hydrocarbon group, or a C4-10 alkylcycloalkyl- or cycloalkyl- group, or an optionally with alkyl group or halogen atom substituted phenyl-, C7-10 alkylaryl- or hetaryl- group, Y represents (CH2), group or 0 atom or S atom, and where n=0-3.
-
(2014/05/20)

COMPOUND AND METHOD
A compound of formula (I): (I) wherein Y is, Z is OR10, NR11R11 SR11, S(0)R11 S02R11, R10 is H, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted heterocyclyl, CO-R11, or a protecting group, and R11 is optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted heterocyclyl, or alkoxyl; a process for making a compound of formula (I); and a process for making a prostaglandin or a prostaglandin analogue using a compound of formula (I).
-
Page/Page column 111; 112

(2014/01/08)

PROCESS FOR PREPARATION OF PROSTAGLANDIN F2α ANALOGUES
A convergent synthesis of the prostaglandin F2α analogues, travoprost and bimatoprost, was developed employing Julia-Lythgoe olefination of the structurally advanced phenylsulfone with an enantiomerically pure aldehyde ω-chain synthon. The novel convergent strategy allows the synthesis of a whole series of prostaglandin analogues of high purity from a common and structurally advanced prostaglandin intermediate.
-
Page/Page column 61; 62

(2013/09/26)

A novel convergent synthesis of the antiglaucoma PGF2α analogue bimatoprost
The 17-phenyl PGF2α analogue bimatoprost (10a) is the most efficacious ocular hypotensive agent currently available for the treatment of glaucoma or ocular hypertension. A novel convergent synthesis of 13,14-en-15-ol prostamideF2α an
Dams, Iwona,Chodyński, Micha?,Krupa, Ma?gorzata,Pietraszek, Anita,Zezula, Marta,Cmoch, Piotr,Kosińska, Monika,Kutner, Andrzej
p. 170 - 179
(2013/08/25)

PROCESS FOR THE PREPARATION OF PROSTAGLANDIN DERIVATIVES
The invention concerns a new process for the preparation of prostaglandin derivatives, in particular prostaglandin F2α derivatives, for example bimatoprost, latanoprost and travoprost, the new intermediates of said process and their use in the preparation of prostagblandin derivatives.
-
Page/Page column 8-9

(2012/02/01)

NOVEL PROCESSES FOR THE PREPARATION OF PROSTAGLANDIN AMIDES
The subject of the invention is process for the preparation of the prostaglandin amides of the general formula I, - where in the formula the bonds marked with dotted lines may be single or double bonds, in the case of double bounds at positions 5,6 and 13,14 they may be in cis or in trans orientation, Q stands for a hydroxyl-group and Z stands for a hydroxyl- or oxo-group, R1 and R2 independently represent hydrogen atom or a straight or branched C1-10 alkyl- or aralkyl- group, optionally substituted with -ONO2 group, or an aralkyl- or aryl- group, which contains heteroatom, R3 represents a straight or branched, saturated or unsaturated C4-6 hydrocarbon group, or a C4-10 alkylcycloalkyl- or cycloalkyl- group, or an optionally with alkyl group or halogen atom substituted phenyl-, C7-10 alkylaryl- or hetaryl- group, Y represents (CH2)n group or 0 atom or S atom, and where n=0-3.
-
(2013/02/27)

PREPARATION OF PROSTAGLANDIN DERIVATIVES
A process for preparing the prostaglandin derivatives is provided, wherein the benzoyl and p-nitrobenzoyl groups are used as the hydroxyl protective groups. A pharmaceutical composition comprising the prostaglandin derivatives is also provided.
-
(2012/02/05)

SYNTHESIS OF PROSTANOIDS
The presently disclosed subject matter provides a method of synthesizing prostaglandins and prostaglandin analogs comprising the ring closing metathesis of compounds of Formula (I). Also provided are novel compounds of Formula (I) and Formula (II). In addition to their use as synthetic intermediates in the presently disclosed methods, compounds of Formula (II) can be used as prostaglandin and/or prostaglandin analog prodrugs.
-
Page/Page column 65

(2011/02/24)

A NOVEL PROCESS FOR THE PREPARATION OF PROSTAGLANDINS AND INTERMEDIATES THEREOF
This invention relates to novel process for the preparation of prostaglandin compounds having formula (K), wherein R is selected from the group consisting of C1-C7 alkyl; C7-C17 aralkyl wherein the aryl group is unsubstituted or substituted with one to three substituents selected from the group consisting of C1-C6 alkyl, halo and CF3; and (CH2)nOR2 wherein n is from 1 to 3 and R2 represents a C6-C10 aryl group which is unsubstituted or substituted with one to three substituents selected from the group consisting of C1-C6 alkyl, halo and CF3; and R1 is selected from OR3 and NHR3 wherein R3 is C1-C6 alkyl, H; and dashed lines represents a double bond or a single bond, is disclosed. Novel intermediates are also disclosed.
-
Page/Page column 26; 37

(2011/06/11)

PROCESS FOR THE PREPARATION OF F-SERIES PROSTAGLANDINS
A process for the synthesis and purification of F-series prostaglandin compounds and synthetic intermediates used to prepare them. The synthetic intermediates are solid and may be purified by precipitation and therefore may form the representative F-series prostaglandin compounds such as latanoprost, bimatoprost, fluprostenol, cloprostenol, and substituted analogs therefrom in highly pure forms.
-
(2011/05/05)

PROCESS FOR THE PREPARATION OF PROSTAGLANDIN DERIVATIVES
The invention concerns a new process for the preparation of prostaglandin derivatives, in particular prostaglandin F2α derivatives, for example bimatoprost, latanoprost and travoprost, the new intermediates of said process and their use in the preparation of prostaglandin derivatives.Said process comprises: a) reacting compounds of formula (I) with compounds of formula (II) to give compounds of formula (III) b) reducing with an asymmetric reducing agent the oxo group of the side chain of compounds of formula (III) to give compounds of formula (IV)
-
Page/Page column 20

(2010/09/17)

IMPROVED PROCESS FOR THE PREPARATION OF PROSTAGLANDINS AND ANALOGUES THEREOF
The present invention relates to an improved process for the preparation of prostaglandin and prostaglandin analogues, particularly PGF2α derivatives.
-
Page/Page column 20

(2010/11/03)

The Meyer-Schuster rearrangement: A new synthetic strategy leading to prostaglandins and their drug analogs, Bimatoprost and Latanoprost
Gold(I) mediated Meyer-Schuster rearrangement for the installation of the 'lower' side chain of prostaglandins and their analogs has been developed. This Au-mediated rearrangement, featuring a low catalyst loading and mild reaction conditions, has been demonstrated to be an efficient alternative to the standard Horner-Wadsworth-Emmons reaction in prostaglandin chemistry. Moreover, the present results provide a new synthetic process leading to pharmacologically active prostanoids: Latanoprost and Bimatoprost, that continue to hold key positions in the anti-glaucoma drug market.
Zanoni, Giuseppe,D'Alfonso, Alessandro,Porta, Alessio,Feliciani, Lazzaro,Nolan, Steven P.,Vidari, Giovanni
experimental part
p. 7472 - 7478
(2010/12/25)

AMINO ACID SALTS OF PROSTAGLANDINS
The present invention is directed to novel amino acid prostaglandin salts and methods of making and using them.
-
Page/Page column 17

(2010/05/13)

AMINO ACID SALTS OF PROSTAGLANDINS
The present invention is directed to novel amino acid prostaglandin salts and methods of making and using them.
-
Page/Page column 19

(2010/05/13)

PROCESS FOR PREPARING PROSTAGLANDIN DERIVATIVES
The present invention relates to a process for preparing a prostaglandin derivative and an intermediate therefor. In accordance with the present invention, the prostaglandin F (PGF) derivative can be efficiently prepared with high purity by removing the protecting group of a protected prostaglandin E (PGE) derivative obtained from conjugate addition and then stereoselectively reducing the ketone group on the cyclopentanone ring of the PGE derivative.
-
Paragraph 106-108

(2010/10/03)

Improved process for the production of bimatoprost
The present invention relates to a process for the purification of crude bimatoprost to obtain pure bimatoprost comprising a chromatography, preferably a chromatography using an achiral stationary phase and an eluent comprising an alcohol and an apolar solvent; and crystallisation of the product obtained the chromatography to obtain pure bimatoprost.
-
Page/Page column 17

(2009/12/28)

Process for the Preparation of Prostaglandin Analogues and Intermediates Thereof
The present application provides intermediates for preparing prostaglandin analogues and processes for preparing prostaglandin analogues and intermediates thereof. The intermediates include: A compound of formula (6): R1 represents H, C1-C5-alkyl, or benzyl, in particular isopropyl.
-
Page/Page column 22-23

(2009/10/21)

Bimatoprost crystalline form I
The invention provides a novel polymorphic form I of crystalline bimatoprost, method for preparation thereof and new crystalline intermediates in the preparation. This form I of crystalline bimatoprost is used in purification of crude bimatoprost and in storage of bimatoprost as active pharmaceutical intermediate. Use of the physical form of bimatoprost in the manufacture of a medicament is also disclosed.
-
Page/Page column 18

(2009/07/10)

PROSTAGLANDIN SYNTHESIS
A process for the preparation of prostaglandin compounds having the formula (I); wherein A is selected from the group consisting Of C1-C6 alkyl; C7-C16 aralkyl wherein the aryl group is optionally substituted with one to three substituents selected from the group consisting Of C1 -C6 alkyl, halo and CF3; and (CH2)nOR' wherein n is from 1 to 3 and R' represents a C6-Cl0 aryl group which is optionally substituted with one to three substituents selected from the group consisting Of C1-C6 alkyl, halo and CF3; B is selected from OR" and NHR" wherein R" is C1-C6 alkyl; and formula (a) represents a double bond or a single bond, is disclosed. Novel intermediates are also disclosed.
-
Page/Page column 46-47

(2008/06/13)

9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
9,11-Cycloendoperoxide derivatives of biologically active prostaglandin analogs, and particularly of the ocular hypotensive drugs Bimatoprost, Latanaprost, Unoprostone, Travoprost and prostaglandin H2 1-ethanolamide or of structurally closely related analogs, are pro-drugs which hydrolyze under physiological conditions to provide prostaglandin analogues that are capable of providing sustained ocular and other in vivo concentrations of the respective drugs. The compounds of the invention have the formula shown below where the variables have the meaning defined in the specification.
-
Page/Page column 13-14

(2010/11/30)

PREPARATION OF PROSTAMIDES
The present invention provides a process for the preparation of a prostamide which comprises the steps of (d) reacting first intermediate having the general formula (I) with DIBAL wherein Z is a protecting group and the dotted line represents the presence or absence of a double bond to yield a second intermediate having the general Formula (II) (b) reacting said second intermediate with Na(TMS)2N and (C6H5)3P+(CH2)6CONR2X wherein R is a C1-5 alkyl or hydrogen and X is an anion to yield a third intermediate having the general formula (III) (c) reacting said third intermediate with a protecting agent to yield a fourth intermediate having the general formula IV (e) reacting said fourth intermediate to remove said protecting groups and yield a prostamide having the general formula V
-
Page/Page column 7

(2008/06/13)

Chemical Properties

Appearance/Colour :crystalline solid
Melting Point: 66-68°C
Boiling Point: 629.8 ºC at 760 mmHg
Flash Point:334.7 ºC
Density: 1.145 g/cm³
Solubility:Chloroform (Slightly), Dichloromethane (Slightly), Methanol (Slightly)
Storage Temp.:−20°C
Vapor Pressure: 9.94E-17mmHg at 25°C
Refractive Index: 1.591
PKA: 14.25±0.20(Predicted)
PSA: 89.79000
LogP: 3.53780

Global suppliers and manufacturers of 155206-00-1total 268 suppliers on LookChem

Company Name
Business Type
Min Order
FOB Price
Main Products
Contact

Xi'an Xszo Chem Co., Ltd.
Business Type:Manufacturers
Min Order:1 Gram
FOB Price:USD $ 0.1-0.1 / Gram
Main Products:108
Country:

Henan Tianfu Chemical Co., Ltd.
Business Type:Lab/Research institutions
Min Order:1 Metric Ton
FOB Price:USD $ 500.0-500.0 / Metric Ton
Main Products:67
Country:

Chemvon Biotechnology Co. Ltd.
Business Type:Lab/Research institutions
Min Order:1 Gram
FOB Price:No Data
Main Products:60
Country:

Sinoway Industrial Co., Ltd.
Business Type:Trading Company
Min Order:1 Gram
FOB Price:USD $ 150.0-150.0 / Gram
Main Products:105
Country:

Hebei Nengqian Chemical Import and Export Co., LTD
Business Type:Trading Company
Min Order:1 Gram
FOB Price:USD $ 12.0-15.0 / Gram
Main Products:162
Country:

Hubei Yuanmeng Biological Technology Co., Ltd.
Business Type:Trading Company
Min Order:1 Kilogram
FOB Price:USD $ 3.0-5.0 / Kilogram
Main Products:43
Country:

Taizhou Crene Biotechnology co.ltd
Business Type:Lab/Research institutions
Min Order:1 Gram
FOB Price:No Data
Main Products:16
Country:

Qiuxian Yanjia Trading Co., Ltd
Business Type:Trading Company
Min Order:1 box
FOB Price:USD $ 190.0-220.0 / box
Main Products:67
Country:

DALIAN BAIJIA IMPORT AND EXPORT CO., LTD
Business Type:Lab/Research institutions
Min Order:No Data
FOB Price:No Data
Main Products:17
Country:

Dayang Chem (Hangzhou) Co.,Ltd.
Business Type:Lab/Research institutions
Min Order:1 Kilogram
FOB Price:USD $ 3.0-3.0 / Kilogram
Main Products:994
Country:

Hangzhou Dingyan Chem Co., Ltd
Business Type:Manufacturers
Min Order:1 Gram
FOB Price:USD $ 100.0-500.0 / Gram
Main Products:95
Country:

Kono Chem Co.,Ltd
Business Type:Other
Min Order:1 Gram
FOB Price:No Data
Main Products:86
Country:

Wuhan Fortuna Chemical Co.,Ltd
Business Type:Trading Company
Min Order:1 Gram
FOB Price:USD $ 700.0-735.0 / Gram
Main Products:51
Country:

Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd
Business Type:Manufacturers
Min Order:1 Gram
FOB Price:No Data
Main Products:86
Country:

Hefei TNJ chemical industry co.,ltd
Business Type:Trading Company
Min Order:100 Gram
FOB Price:No Data
Main Products:56
Country:

Hangzhou Think Chemical Co. Ltd
Business Type:Other
Min Order:1 Gram
FOB Price:No Data
Main Products:165
Country:

Henan Allgreen Chemical Co.,Ltd
Business Type:Manufacturers
Min Order:1 Kilogram
FOB Price:No Data
Main Products:34
Country:

Ality Chemical Corporation
Business Type:Other
Min Order:1
FOB Price:No Data
Main Products:165
Country:

Xi`an Eastling Biotech Co., Ltd.
Business Type:Lab/Research institutions
Min Order:1 Gram
FOB Price:USD $ 159.0-170.0 / Gram
Main Products:21
Country:

Shanghai Seasonsgreen Chemical Co.,Ltd
Business Type:Manufacturers
Min Order:1 Kilogram
FOB Price:USD $ 1.0-1.0 / Kilogram
Main Products:36
Country:

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 155206-00-1

Article Database

155206-00-1

Articles about 155206-00-1Total 34 be found

More Articles about upstream products of 155206-00-1

More Articles about downstream products of 155206-00-1

Chemical Properties

Appearance/Colour :crystalline solid

Melting Point: 66-68°C

Boiling Point: 629.8 ºC at 760 mmHg

Flash Point:334.7 ºC

Density: 1.145 g/cm³

Solubility:Chloroform (Slightly), Dichloromethane (Slightly), Methanol (Slightly)

Storage Temp.:−20°C

Vapor Pressure: 9.94E-17mmHg at 25°C

Refractive Index: 1.591

PKA: 14.25±0.20(Predicted)

PSA: 89.79000

LogP: 3.53780

Global suppliers and manufacturers of 155206-00-1total 268 suppliers on LookChem

Article Database

155206-00-1

Articles about 155206-00-1Total 34 be found

More Articles about upstream products of 155206-00-1

More Articles about downstream products of 155206-00-1

Chemical Properties

Appearance/Colour :crystalline solid

Melting Point: 66-68°C

Boiling Point: 629.8 ºC at 760 mmHg

Flash Point:334.7 ºC

Density: 1.145 g/cm3

Solubility:Chloroform (Slightly), Dichloromethane (Slightly), Methanol (Slightly)

Storage Temp.:−20°C

Vapor Pressure: 9.94E-17mmHg at 25°C

Refractive Index: 1.591

PKA: 14.25±0.20(Predicted)

PSA: 89.79000

LogP: 3.53780

Global suppliers and manufacturers of 155206-00-1total 268 suppliers on LookChem

Density: 1.145 g/cm³